Abstracts

Citation

Raltegravir (RAL Pharmacokinetics (PK) and Safety in Neonates (IMPAACT P1097). Presented at: 13th International Workshop on Clinical Pharmacology of HIV Therapy.

Citation

Diana F. Clarke, Edward P. Acosta, Matthew Rizk, Yvonne Bryson, Stephen A. Spector, Lynne Mofenson, Mary Elizabeth Smith, Hedy Teppler, Carolee Welebob, Mae Cababasay, Bobbie Graham, Kat Richards, Mark Mirochnick , the P1110 Protocol Team. Raltegravir (RAL) pharmacokinetics (PK) and safety in HIV-1 exposed neonates at high risk of infection (IMPAACT P1110). Presented at: IAS 2015; 2015 Jul 20.

Citation

Diana Clarke, Edward Acosta, Matthew Rizk, Yvonne Bryson, Stephen Spector, Lynne Mofenson, Mary Elizabeth Smith, Hedy Teppler, Carolee Welebob, Mae Cababasay, Bobbie Graham, Kat Richards, Mark Mirochnick, P1110 Protocol Team. Raltegravir (RAL) Pharmacokinetics (PK) in HIV-1 Exposed Neonates at High Risk of Infection. Presented at: IAS 2015.

Citation

Jos Lommerse, Diana F Clarke, Anne Chain, Han Witjes, Hedy Teppler, Edmund Capparelli, Edward P Acosta, Matthew Rizk, Larissa Wenning, Thomas Kerbusch, Stephen A Spector, Betsy Smith, Mark Mirochnick. Raltegravir dosing in neonates (IMPAACT P1110) – Use of allometry and PK modeling to develop a daily dosing regimen for investigation during first weeks of life. Presented at: Population Approach Group in Europe (PAGE) Meeting.

Citation

Jos Lommerse, Diana Clarke, Anne Chain, Han Witjes, Hedy Teppler, Edmund Capparelli, Edward Acosta, Matthew Rizk, Larissa Wenning, Thomas Kerbusch, Stephen Spector, Betsy Smith, Mark Mairochnick. Raltegravir dosing in neonates (IMPAACT P1110) – Use of allometry and PK modeling to develop daily dosing strategy for investigation during first weeks of life. Presented at: Population Approach Group in Europe (PAGE) Meeting.

Citation

Hedy Teppler, Brenda Homony, Carolee Welebob, Xia Xu, Matthew Rizk, Elizabeth Rhee. Raltegravir Pediatric Development: New Options for Treating the Youngest Children with HIV. Presented at: International Pediatric HIV Workshop 2014.

Citation

DF Clarke, EP Acosta, A Chain, J Wang, M Cababasay, H Teppler, E Smith, R Hazra, M Mirochnick, IMPAACT P1110 Protocol Team. Raltegravir pharmacokinetics and safety in HIV-1 exposed neonates: dose-finding study. Presented at: CROI 2017; 2017 Feb 16.

Citation

Raltegravir Pharmacokinetics and Safety in Neonates (IMPAACT P1097). Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Raltegravir Pharmacokinetics during Pregnancy. Presented at: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.

Citation

Edward P. Acosta, Pharm.D., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Hedy Teppler, M.D., Mary C. Long, Ph.D., B. Homony, Edward Handelsman, M.D., Carol J. Worrell, M.D., Terence Fenton, Ed.D. Raltegravir pharmacokinetics in adolescents: preliminary results from IMPAACT protocol 1066. Presented at: 9th Int'l Workshop on Clinical Pharmacology of HIV Therapy.